← Back to Clinical Trials
Recruiting NCT04994756

NCT04994756 Stroke Thrombectomy and Aneurysm Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04994756
Status Recruiting
Phase
Sponsor Medical University of South Carolina
Condition Stroke
Study Type OBSERVATIONAL
Enrollment 40,000 participants
Start Date 2019-09-17
Primary Completion 2055-01-01

Eligibility & Interventions

Sex All sexes
Min Age 1 Year
Max Age 120 Years
Study Type OBSERVATIONAL
Interventions
Stroke/Thrombectomy/Aneurysm-specific surgical procedures

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 40,000 participants in total. It began in 2019-09-17 with a primary completion date of 2055-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This international multi-center registry is used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an artery, abnormal tangling of blood vessels, abnormal formation of blood vessels, tearing of vein, and bleeding in the brain. This information is used to help predict outcomes that undergo an operation for treatment of the above-listed brain injuries. Additionally, the information is used to compare techniques and devices' effects on technical and clinical outcomes.

Eligibility Criteria

Inclusion Criteria: * Undergoing surgical intervention for central nervous system vascular lesion * Between 1 and 120 years of age Exclusion Criteria: * No exclusion criteria

Contact & Investigator

Central Contact

Alejandro M Spiotta, MD

✉ spiotta@musc.edu

📞 843-792-9226

Principal Investigator

Meredith Robinson, MS

STUDY DIRECTOR

Medical University of South Carolina

Frequently Asked Questions

Who can join the NCT04994756 clinical trial?

This trial is open to participants of all sexes, aged 1 Year or older, up to 120 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04994756 currently recruiting?

Yes, NCT04994756 is actively recruiting participants. Contact the research team at spiotta@musc.edu for enrollment information.

Where is the NCT04994756 trial being conducted?

This trial is being conducted at Birmingham, United States, Loma Linda, United States, Santa Barbara, United States, Danbury, United States and 11 additional locations.

Who is sponsoring the NCT04994756 clinical trial?

NCT04994756 is sponsored by Medical University of South Carolina. The principal investigator is Meredith Robinson, MS at Medical University of South Carolina. The trial plans to enroll 40,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology